Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|May 23, 2018
Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Cureus|June 24, 2022
A Prospective Multicenter Study to Evaluate the Safety and Efficacy of the Topical Application of MYOWNN™, an Autologous Growth Factor Concentrate (AGFC) Serum, in Anti-AgingB S Chandrashekar, Kalpana Sarangi, Mushtaque A Mastim, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Single-Center Investigation of the Pharmacokinetics of WCK 4282 (Cefepime-Tazobactam Combination) in Renal ImpairmentRichard A Preston, Grigor Mamikonyan, Mushtaque Mastim, et al.
Acta Diabetologica|February 18, 2018
Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus®) and Lantus® in healthy subjects: a double-blind, randomized clamp studyAshima Bhatia, Shraddha Tawade, Mushtaque Mastim, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2018
Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal ImpairmentRichard A Preston, Grigor Mamikonyan, Stephane DeGraff, et al.
Cureus|December 7, 2022
An Open-Labeled Randomized Prospective Multi-center Study to Evaluate the Efficacy and Safety of Intra-articular Injection of OSSINEXT™, an Autologous Growth Factor Concentrate (AGFC) Compared to Hyaluronic Acid (HA) in Knee OsteoarthritisMushtaque A Mastim, Chirag Borana, Vrajesh Shah, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 22, 2025
Efficacy and safety of elobixibat in patients with chronic constipation-A randomized, multicenter, double-blind, placebo-controlled, parallel-group study from IndiaPiyush Agarwal, Brajesh Kumar Jha, Jaganmohan Somagoni, et al.
Drug Design, Development and Therapy|January 11, 2020
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current EvidenceSachin S Bhagwat, Manohar Nandanwar, Atul Kansagara, et al.
Pageof 2